Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Immunohistochemistry (IHC) Market between 2026 and 2030?

The immunohistochemistry (ihc) market size has expanded considerably in recent years. It is projected to grow from $2.76 billion in 2025 to $3.05 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.3%. The growth observed in the preceding period can be attributed to factors such as the increasing application of ihc in cancer diagnostics, the establishment of more hospital pathology laboratories, enhanced access to monoclonal antibodies, a rising inclination towards tissue-based diagnostics, and intensified clinical research endeavors.

The immunohistochemistry (IHC) market is projected to experience substantial expansion in the coming years, anticipated to reach a valuation of $4.47 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.1%. This projected growth is primarily driven by factors such as a heightened demand for precision oncology diagnostics, the increasing embrace of AI-enabled pathology analysis, the broadening scope of biomarker-driven drug development, the expanding application of multiplex tissue profiling, and greater investments in sophisticated pathology infrastructure. Key trends anticipated during the forecast period encompass a wider adoption of automated IHC staining systems, an increase in the utilization of multiplex IHC techniques, the progressive integration of digital pathology platforms, the expansion of companion diagnostic uses, and a sharpened focus on high-specificity antibodies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9267&type=smp

Which Drivers Are Expected To Impact The Immunohistochemistry (IHC) Market During The Forecast Period?

The increasing need for personalized medicines is anticipated to boost the expansion of the immunohistochemistry (IHC) market in the future. Personalized medicine represents a healthcare strategy focused on customizing medical choices, procedures, treatments, and goods for each patient, considering their distinct genetic makeup, environmental factors, and lifestyle. Immunohistochemistry (IHC) holds crucial importance in personalized medicine, being employed to identify particular protein markers which aid in precise tumor categorization and diagnosis. For example, in February 2024, data from the Personalized Medicine Coalition, a US-based non-profit research organization, indicated that personalized medicines constituted more than one-third of new approvals by the US Food and Drug Administration in 2023. During the identical year, the FDA sanctioned 16 new personalised treatments for rare-disease patients, an increase from 6 in 2022. Consequently, the escalating demand for personalized medicines is fueling the expansion of the immunohistochemistry (IHC) market.

How Is The Immunohistochemistry (IHC) Market Divided Into Segments?

The immunohistochemistry (ihc) market covered in this report is segmented –

1) By Product: Antibodies, Equipment, Reagents, Kits

2) By Applications: Diagnostics, Drug Testing, Other Applications

3) By End-Users: Hospitals And Diagnostic Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Antibodies: Primary Antibodies, Secondary Antibodies, Conjugated Antibodies

2) By Equipment: IHC Staining Systems, Slide Scanners, Microscopes

3) By Reagents: Detection Reagents, Blocking Reagents, Mounting Media

4) By Kits: Pre-prepared IHC Kits, Multiplex IHC Kits, Specialty Kits

Which Trends Are Guiding The Evolution Of The Immunohistochemistry (IHC) Market?

Leading companies within the immunohistochemistry (IHC) market are intensely focused on enhancing diagnostic precision by leveraging innovative technologies and premium reagents, thus improving the effectiveness of tissue analysis in various clinical and research settings. The Neoflex multiomics mass spectrometry imaging (MSI) system stands as a sophisticated imaging platform specifically designed for accurate tissue examination. It empowers researchers to move from initial discovery stages into clinical applications through high-resolution mass spectrometry techniques, particularly for the spatial mapping of biomolecules in tissues. For example, in June 2024, Bruker Corporation, a US-based firm specializing in scientific instruments and analytical and diagnostic solutions, unveiled its matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF/TOF) Neoflex Imaging Profiler for mass spectrometry-based tissue imaging. This Neoflex multiomics mass spectrometry imaging (MSI) system aims to meet the demand for advancing from discovery imaging to clinical tissue research. It is equipped with Bruker’s 10-kHz smartbeam 3D laser, features enhanced imaging detectors, and facilitates OME-TIFF file output via SCiLS Scope software.

Which Leading Companies Dominate The Immunohistochemistry (IHC) Market Share?

Major companies operating in the immunohistochemistry (ihc) market are Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Merck Group, Danaher Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., Cell Signaling Technology Inc., Bio SB Inc., Agilent Technologies Inc., Abcam plc, Takara Bio Inc., Biocare Medical LLC, Bio-Genex Laboratories, Diagnostic BioSystems Inc., PHC Holdings Corporation, Leica Biosystems, Vector Laboratories, Ionpath Inc., Reveal Biosciences, Akrivis Technologies Private Limited, LifeSpan BioSciences Inc., Enzo Life Sciences Inc., Epitomics Inc., GenScript Biotech

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/immunohistochemistry-ihc-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Immunohistochemistry (IHC) Market?

North America was the largest region in the immunohistochemistry (IHC) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the immunohistochemistry (IHC) market report during the forecast period. The regions covered in the immunohistochemistry (ihc) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Immunohistochemistry (IHC) Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9267&type=smp

Browse Through More Reports Similar to the Global Immunohistochemistry (IHC) Market 2026, By The Business Research Company

Immunohematology Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Immunoassay Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report

Immunotoxin Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/immunotoxin-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company